BR112013017851A2 - método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii - Google Patents

método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii

Info

Publication number
BR112013017851A2
BR112013017851A2 BR112013017851A BR112013017851A BR112013017851A2 BR 112013017851 A2 BR112013017851 A2 BR 112013017851A2 BR 112013017851 A BR112013017851 A BR 112013017851A BR 112013017851 A BR112013017851 A BR 112013017851A BR 112013017851 A2 BR112013017851 A2 BR 112013017851A2
Authority
BR
Brazil
Prior art keywords
reducing type
collagen levels
telopeptide collagen
telopeptide
levels
Prior art date
Application number
BR112013017851A
Other languages
English (en)
Inventor
Wedekind Karen
Ruff Kevin
Original Assignee
Esm Tech Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esm Tech Llc filed Critical Esm Tech Llc
Publication of BR112013017851A2 publication Critical patent/BR112013017851A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013017851A 2011-01-10 2012-01-09 método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii BR112013017851A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161431238P 2011-01-10 2011-01-10
PCT/US2012/020638 WO2012096883A1 (en) 2011-01-10 2012-01-09 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints

Publications (1)

Publication Number Publication Date
BR112013017851A2 true BR112013017851A2 (pt) 2018-09-18

Family

ID=46507394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013017851A BR112013017851A2 (pt) 2011-01-10 2012-01-09 método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii

Country Status (9)

Country Link
US (1) US20130337080A1 (pt)
EP (1) EP2663317A4 (pt)
JP (1) JP2014507411A (pt)
CN (1) CN103561753A (pt)
AU (1) AU2012205808A1 (pt)
BR (1) BR112013017851A2 (pt)
CA (1) CA2824380A1 (pt)
RU (1) RU2013134126A (pt)
WO (1) WO2012096883A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2009013265A (es) 2007-06-06 2010-01-25 Novus Int Inc Suplementos alimenticios para la promocion de crecimiento, reparacion y mantenimiento de huesos y articulaciones.
JP6056064B2 (ja) * 2013-11-29 2017-01-11 国立大学法人 東京大学 卵殻膜成分を含むインスリン抵抗性改善剤ならびにそれを用いた組成物
CN103951596A (zh) * 2014-05-15 2014-07-30 河北一品制药有限公司 一种药用消旋羟蛋氨酸钙的制备方法
CN104146260B (zh) * 2014-08-27 2015-10-28 山东省疾病预防控制中心 一种增加骨密度的保健食品及其制备方法
PL3212204T3 (pl) 2014-10-28 2019-11-29 Biovotec As Mikronizowane cząstki błony skorupki jaja i ich zastosowanie dla pobudzania gojenia ran
FI11062U1 (fi) 2015-05-29 2015-12-08 Vetcare Oy Täydennysrehukoostumus eläimille
US11045578B2 (en) 2015-06-24 2021-06-29 Biovotec As Tissue engineering scaffolds comprising particulate egg shell membrane
GB201519923D0 (en) 2015-11-11 2015-12-23 Biovotec Dac And Biovotec As Dry biocompatible disintegrateable films for delivering particulate egg shell membrane to a wound
GB2551237B (en) * 2016-06-08 2019-10-02 Lo Dough Ltd Bakery food product
AU2020224843A1 (en) * 2019-02-20 2021-08-19 Suntory Holdings Limited Protein-containing oral composition and method for improving flavor of protein-containing oral composition
WO2020186057A1 (en) * 2019-03-12 2020-09-17 Novus International Inc. Biomarkers for joint ailments and uses thereof
KR102361526B1 (ko) * 2019-07-02 2022-02-11 한국 한의학 연구원 난각막을 유효성분으로 함유하는 고요산혈증 또는 고요산혈증 관련 대사 장애의 예방, 개선 또는 치료용 조성물
KR102168587B1 (ko) * 2020-04-29 2020-10-21 지혜민 반려동물 관절 영양제 조성물
CN111826343A (zh) * 2020-07-23 2020-10-27 北京中卫医正科技有限公司 一种增强诱导软骨分化的细胞培养液、方法及应用
CN114931571A (zh) * 2022-03-30 2022-08-23 上海中医药大学附属曙光医院 没食子酸甲酯在制备骨关节炎治疗药物中的应用
WO2023215454A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Chondroitin- and collagen peptide-based methods for slowing down aging and extending lifespan

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040180025A1 (en) * 2003-03-12 2004-09-16 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US20080063677A1 (en) * 2004-03-10 2008-03-13 New Life Resources, Llc Therapeutic, nutraceutical and cosmetic applications for eggshell membrane and processed eggshell membrane preparations
US8580315B2 (en) * 2004-03-10 2013-11-12 Esm Technologies, Llc Anti-inflammatory activity of eggshell membrane and processed eggshell membrane preparations
MX2009013265A (es) * 2007-06-06 2010-01-25 Novus Int Inc Suplementos alimenticios para la promocion de crecimiento, reparacion y mantenimiento de huesos y articulaciones.
WO2009052396A2 (en) * 2007-10-17 2009-04-23 Biova, L.L.C. Novel process for solubilizing protein from a proteinaceous material and compositions thereof
US8481072B2 (en) * 2009-07-23 2013-07-09 U.S. Nutraceuticals, LLC Composition and method to alleviate joint pain
US20110135627A1 (en) * 2009-10-07 2011-06-09 The Inflasoothe Group, Inc. Pain relief composition, system and method
US20110117207A1 (en) * 2009-11-17 2011-05-19 U.S. Nutraceuticals, LLC d/b/a Valensa International State of Incorporation: Use of eggshell membrane formulations to alleviate joint pain

Also Published As

Publication number Publication date
WO2012096883A1 (en) 2012-07-19
CA2824380A1 (en) 2012-07-19
RU2013134126A (ru) 2015-02-20
JP2014507411A (ja) 2014-03-27
CN103561753A (zh) 2014-02-05
EP2663317A1 (en) 2013-11-20
AU2012205808A8 (en) 2013-09-12
AU2012205808A1 (en) 2012-07-19
EP2663317A4 (en) 2014-06-04
US20130337080A1 (en) 2013-12-19

Similar Documents

Publication Publication Date Title
BR112013017851A2 (pt) método para reduzir níveis de colágeno de c-telopeptídeo do tipo ii
BR112014015562A2 (pt) aerofólio e método para fabricar um aerofólio
CO6930366A2 (es) Método para el tratamiento de vhc
CO6950446A2 (es) Mecanismo y método de sellado para empalme de cable de bajada
BR112013021970A2 (pt) controle para trilho móvel
BR112014009528A2 (pt) métodos e composições para tratar eritropoiese ineficaz
BR112014006702A2 (pt) método para tratar osteoporose
BR112014007958A2 (pt) método
BR112014007266A2 (pt) método para fornecer anúncio personalizado
BR112014001237A2 (pt) método
BR112013024520A2 (pt) método para preparar uma composição adsorvente,em, dispositivo de purificação de àgua
BR112014001851A2 (pt) método
BR112013002290A2 (pt) método para controlar estrutura de cadeia de copolímeros
BR112013008835A2 (pt) método de dinamitação para benificiamento de minerais
BR112014010450A2 (pt) composição e método
BR112014003265A2 (pt) método para produzir vanilina
BR112014009795A2 (pt) método
BR112013030423A2 (pt) método para produção de biocoque
BR112013003535A2 (pt) método para formar espuma
BR112013007298A2 (pt) método para produzir composição de borracha
BR112013023465A2 (pt) método para produzir l-cisteína
BR112014000243A2 (pt) método para o controle de névoa
BR112014014285A2 (pt) composição, e, método para fabricar uma composição
BRDI7105327S (pt) Configuração aplicada em estojo para peças de dominó
BR112014010860A2 (pt) composição e método

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001

B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 6A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30/10/2018.